Does caffeine intake protect from Alzheimer's disease? - Wikidata - awgldk - TriplyDB

Does caffeine intake protect from Alzheimer's disease?

Does caffeine intake protect from Alzheimer's disease?

http://www.wikidata.org/entity/Q44051650

about

Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?Caffeine: cognitive and physical performance enhancer or psychoactive drug?Alzheimer's disease and diet: a systematic review.The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle Habitual coffee consumption enhances attention and vigilance in hemodialysis patients Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity Chronic caffeine ingestion causes microglia activation, but not proliferation in the healthy brain Caffeine attenuates lipopolysaccharide-induced neuroinflammation.Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence.Genetics of caffeine consumption and responses to caffeine.The consequence of errors. From memory molecules to the criminal chromosome, erroneous conclusions continue to blight scientific research.Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer's Disease Therapy.Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice.Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.Health benefits of methylxanthines in cacao and chocolate.Effectiveness of topical caffeine in cataract prevention: studies with galactose cataract.Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.Caffeine: neuroprotective functions in cognition and Alzheimer's disease.Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease The relevance of theobromine for the beneficial effects of cocoa consumption.Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease.Treatment of cognitive impairment in Alzheimer's disease Stuck at the bench: Potential natural neuroprotective compounds for concussion.Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma.From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?Plasticity of purine release during cerebral ischemia: clinical implications?Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells.Lifestyle Factors and Dementia in the Oldest-old: The 90+ Study.Inconsistency of Association between Coffee Consumption and Cognitive Function in Adults and Elderly in a Cross-Sectional Study (ELSA-Brasil)Effect of coffee (caffeine) against human cataract blindness.Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease

P2860

Q24606390-1B0285E7-86BA-4DB3-B0C1-0A41FD49DB84 Q24672753-1F094AB6-C7CC-44DF-8928-303D94FCF7F2 Q26740559-2CE4F1D2-B286-4C6A-93B4-98882A486FDD Q26750581-F4F1A6FE-705D-47B4-8590-8487D1ACF6FD Q26859305-105D59F4-E59C-4E5B-95AE-349CBDDFBBC5 Q28080581-7AC471C6-05C1-4D38-982F-9CD63AA31920 Q30251902-77760143-3F23-4ED0-8D29-BEA982797C81 Q30668465-08293351-5408-4842-BADF-CED291DC76E5 Q33584772-8CA8AFD3-905E-450D-91DD-F25E9A358FEF Q33634733-2A5A02B6-AFD2-4320-B2C3-DA0B3F9C0BE5 Q33770432-52DA8829-DE1B-4355-9B9B-5EE53121210E Q33954408-2C8D5D18-5BEC-4365-96D2-217E43EEBF0E Q34002675-D0649F24-31B9-430D-8E92-61877B8CE0AC Q34088937-9B371E14-1993-495C-9F42-FAE8A0ACF4E3 Q34119748-5AFBE597-0573-4DE2-9B30-FB1B1EA41354 Q34166783-B430ADB3-26FB-4934-A4E0-FBA4CA645B22 Q34177869-AB252E23-6ECF-400F-990A-6A533346058E Q34238362-504162E9-5900-4AF6-9682-749C313FF9BD Q34353553-FF994E3B-353D-4271-B56A-1502653B65E5 Q34379254-A49813BE-C42C-450C-AF59-A7A924B3F138 Q34410773-2CDB336C-F11B-4F46-A29A-E6DB8CF6070C Q34465295-21601EC7-B81B-45C5-AF4E-29001AF0CA1E Q34499277-4360F3DC-B6E5-4EB2-A4BD-657A4BDA2057 Q34905120-C31E4A8D-C583-46AD-AD5A-42A506209264 Q34948869-13EFA434-3371-491A-9EB6-96534D0E5793 Q35030119-D4613DE9-43C1-4F7F-AB05-9E22A7F2CCD7 Q35104091-E0374AD2-D8CB-4A39-ABA1-7ABFFD58F2F9 Q35184647-310F5A1B-2357-4477-A0D4-70911F733242 Q35236559-07EB8B93-1B0A-42FD-B0FF-F1BFB218DE28 Q35493114-6E351191-35F2-4EE9-B408-AED5681C4FB0 Q35546008-2F2860AF-4C0F-4358-9BDA-429AEE193F81 Q35577011-1B88B334-9E11-4ED8-B009-3B1BB36A68D0 Q35634105-736DE82B-417B-4B73-A0B0-DA5307123C2D Q35644634-60DEDE33-8CEC-4CE3-840C-4B70FB8B9010 Q35894504-85D53700-B6D5-4E0C-9EC4-2FCECF4323AC Q36031659-8E0ED9A3-5AA5-4445-8006-62FA136CAB7B Q36329946-EAE47ED4-42CF-4A23-90C7-B956E547E035 Q36525830-8A5CBCCC-5DE6-45C6-963D-DBED6D9C0D76 Q36543057-4667D160-60BA-4884-B487-46349FCF7EC2 Q36580195-5244FB82-82CE-4F27-894E-A0C1FA664DEA

P2860

Does caffeine intake protect from Alzheimer's disease?

http://www.wikidata.org/entity/Q44051650

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Does caffeine intake protect from Alzheimer's disease?

@en

Does caffeine intake protect from Alzheimer's disease?

@nl

type

label

Does caffeine intake protect from Alzheimer's disease?

@en

Does caffeine intake protect from Alzheimer's disease?

@nl

prefLabel

Does caffeine intake protect from Alzheimer's disease?

@en

Does caffeine intake protect from Alzheimer's disease?

@nl

P1433

Q44051650-10FBF1E8-FD0F-41BD-903A-2642071A82BC

P1476

Q44051650-EEF6DE93-B42C-4248-A095-053973DB4C7B

P2093

Q44051650-3BC8500E-A017-48F5-9515-344DB10FD02D

P2860

Q44051650-09C4FC2C-CD90-48D1-8506-7B061B280370

Q44051650-16C08FDD-168B-42AE-8855-E2ED178736F1

Q44051650-2EFD3376-07EC-4297-9B5D-4E5B885B005F

Q44051650-337186CF-8C26-4975-8B45-2B77AFA02538

Q44051650-3DE79BB3-F78F-413F-ABB9-C2EF028DF8D0

Q44051650-3E598085-CB52-45C7-A9D8-0A0790CF3409

Q44051650-41E38AC0-F54C-4CDB-AE60-42127F6CFB97

Q44051650-4B152106-8E2F-4D14-86D3-101B8BFCCB75

Q44051650-4F54898E-BEB8-4E62-B9D3-858456F64252

Q44051650-57DEB482-D06C-4F45-9AAC-C3B06A1984DA

P304

Q44051650-E9B1A615-C628-470F-AF87-4A5AC48EC14A

P31

Q44051650-E12033F0-1FC0-4A66-ADF3-71D12539437B

P356

Q44051650-4C0886F2-8928-418F-9471-4BB1AF48E2FD

P433

Q44051650-18BD5DAA-15F5-45CD-BE6A-309024CB7D02

P478

Q44051650-3DABDF04-3731-4622-951E-D7D80510B927

P50

Q44051650-916EDA68-DF0E-4BFA-8DD4-D40C982F22BF

P577

Q44051650-202E1B33-3DBF-43CE-AE7C-E4BAAAE6BBD1

P5875

Q44051650-59C11DEE-171E-40F2-BA8C-D52776DB8291

P698

Q44051650-56BAA741-6632-4138-B6B3-A923C8EF3826

P921

Q44051650-2C50895B-C8B1-4FBA-828B-053E3C00FCF6

P356

J.1468-1331.2002.00421.X

P1433

European Journal of Neurology

P1476

Does caffeine intake protect from Alzheimer's disease?

@en

P2093

L Maia

http://www.w3.org/2001/XMLSchema#string

P2860

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Alzheimer's disease: a review of the disease, its epidemiology and economic impact.

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.

Clinical trials in dementia with propentofylline.

P304

377-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1468-1331.2002.00421.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Alexandre de Mendonça

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11276158

http://www.w3.org/2001/XMLSchema#string

P698

12099922

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease